173 related articles for article (PubMed ID: 112008)
1. Controlled ex-vivo effect of sulfinpyrazone on platelet function of myocardial infarction patients.
Cortellaro M; Fassio G; Boschetti C; Basagni M; Polli EE
Haematologica; 1979 Apr; 64(2):173-89. PubMed ID: 112008
[No Abstract] [Full Text] [Related]
2. The effect of ticlopidine on platelet functions in acute myocardial infarction. A double blind controlled trial.
Knudsen JB; Kjøller E; Skagen K; Gormsen J
Thromb Haemost; 1985 Jun; 53(3):332-6. PubMed ID: 3901391
[TBL] [Abstract][Full Text] [Related]
3. A controlled study of the effect of sulfinpyrazone on platelet survival and on platelet-bound 14C-serotonin release in patients with previous myocardial infarction.
Cortellaro M; Boschetti C; Fassio G; Basagni M; Polli EE
Acta Haematol; 1979; 61(2):68-74. PubMed ID: 217218
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of therapy with platelet antiaggregants for threatened stroke.
The Canadian Cooperative Stroke Study Group
Can Med Assoc J; 1980 Feb; 122(3):293-6. PubMed ID: 6989457
[No Abstract] [Full Text] [Related]
5. Sulfinpyrazone in the prevention of cardiac death after myocardial infarction. The Anturane Reinfarction Trial.
Anturane Reinfarction Trial Research Group
N Engl J Med; 1978 Feb; 298(6):289-95. PubMed ID: 340942
[TBL] [Abstract][Full Text] [Related]
6. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
Friedman LM
Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
[TBL] [Abstract][Full Text] [Related]
7. [Current clinical results of antiplatelet medication].
Ordinas A
Sangre (Barc); 1984; 29(4-C):833-40. PubMed ID: 6393391
[No Abstract] [Full Text] [Related]
8. Sulfinpyrazone and platelet function in hypertensive patients.
Davi G; Novo S; Gullotti D; Avellone G; Sofia MA; Strano A
Thromb Haemost; 1984 Jul; 51(3):413. PubMed ID: 6388015
[No Abstract] [Full Text] [Related]
9. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct].
Rühle H
Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541
[No Abstract] [Full Text] [Related]
10. Sulfinpyrazone decreases epinephrine-induced platelet aggregation after myocardial infarction.
Latour JG; Theroux P; Bourassa MG
Am J Cardiol; 1982 Nov; 50(5):938-44. PubMed ID: 6753559
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
Cairns JA
Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983
[No Abstract] [Full Text] [Related]
12. [The platelet inhibitor problem].
Straub PW
Schweiz Med Wochenschr; 1981 Apr; 111(14):478-82. PubMed ID: 7015489
[TBL] [Abstract][Full Text] [Related]
13. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Sherry S
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
[No Abstract] [Full Text] [Related]
14. [Antiplatelet drugs (author's transl)].
Dechavanne M; Follea G; Trzeciak MC
Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
[TBL] [Abstract][Full Text] [Related]
15. The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.
Spiel AO; Mayr FB; Ladani N; Wagner PG; Schaub RG; Gilbert JC; Jilma B
Platelets; 2009 Aug; 20(5):334-40. PubMed ID: 19637097
[TBL] [Abstract][Full Text] [Related]
16. Role of blood platelets in coronary artery disease.
Haft JI
Am J Cardiol; 1979 Jun; 43(6):1197-206. PubMed ID: 35967
[TBL] [Abstract][Full Text] [Related]
17. Treatment with sulfinpyrazone of essential mixed cryoglobulinemia.
Boschetti C; Cortellaro M; Invernizzi F; Massaro P; Rigolone A; Polli E
Boll Ist Sieroter Milan; 1985; 64(1):55-8. PubMed ID: 3159402
[TBL] [Abstract][Full Text] [Related]
18. In vivo platelet hyperactivity and factor VIII related antigen increase long after myocardial infarction. A controlled effect of sulfinpyrazone.
Cortellaro M; Boschetti C; Beggi P; Polli EE
Scand J Haematol; 1981 Feb; 26(2):106-14. PubMed ID: 6454960
[TBL] [Abstract][Full Text] [Related]
19. A serial study of platelet reactivity throughout the first six months after myocardial infarction: its modification by sulphinpyrazone.
Kubik MM; Richardson SG
Postgrad Med J; 1987 May; 63(739):351-6. PubMed ID: 3118351
[TBL] [Abstract][Full Text] [Related]
20. [Clinical application and evaluation of anti-platelet agents].
Yasunaga K
Nihon Rinsho; 1978 Dec; 36(12):3884-94. PubMed ID: 372628
[No Abstract] [Full Text] [Related]
[Next] [New Search]
